Stockreport

Brickell Biotech Completes Merger with Vical

Brickell Biotech, Inc.  (BBI) 
PDF Newly Nasdaq-listed BBI focused on developing differentiated therapeutics for treatment of dermatologic disorders Merger brings $60 Million in Combined Cash from Vical [Read more]